ProCE Banner Activity

FAQs: The Expanding Role of Antibody–Drug Conjugates in Breast Cancer

Clinical Thought

In this commentary, expert faculty address questions about the emerging data on the potential expanding role of antibody–drug conjugates in the management of breast cancer.

Released: July 21, 2023

Share

Faculty

Sara A. Hurvitz

Sara A. Hurvitz, MD, FACP

Professor of Medicine
Director
Breast Cancer Clinical Trials Program
Division of Hematology/Oncology
David Geffen School of Medicine
Medical Director
Clinical Research Unit
Jonsson Comprehensive Cancer Center
University of California, Los Angeles
Los Angeles, California

Aditya Bardia

Aditya Bardia, MD, MPH

Director, Breast Cancer Research
Associate Professor
Harvard Medical School
Attending Physician
Massachusetts General Hospital
Boston, Massachusetts

Shanu Modi

Shanu Modi, MD

Full Member and Professor of Medicine
Breast Medicine Service; Department of Medicine 
Attending Physician 
Medicine 
Memorial Sloan Kettering Cancer Center 
New York, New York 

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca, Daiichi Sankyo, Inc., and Gilead Sciences, Inc.

AstraZeneca

Daiichi Sankyo

Gilead Sciences, Inc.

Faculty Disclosure

Primary Author

Aditya Bardia, MD, MPH

Director, Breast Cancer Research
Associate Professor
Harvard Medical School
Attending Physician
Massachusetts General Hospital
Boston, Massachusetts

Aditya Bardia, MD, MPH: consultant/advisor: Daiichi Sankyo/AstraZeneca, Foundation Medicine, Genentech, Immunomedics/Gilead, Lilly, Merck, Novartis, Pfizer, Phillips, Radius Health, Sanofi; researcher (paid to institution): Daiichi Sankyo/AstraZeneca, Genentech, Immunomedics/Gilead, Lilly, Merck, Novartis, Pfizer, Radius Health, Sanofi.

Shanu Modi, MD

Full Member and Professor of Medicine
Breast Medicine Service; Department of Medicine 
Attending Physician 
Medicine 
Memorial Sloan Kettering Cancer Center 
New York, New York 

Shanu Modi, MD: consultant/advisor/speaker: AstraZeneca, Daiichi Sankyo, Genetech, Gilead, Seattle Genetics; researcher: AstraZeneca, Daiichi Sankyo, Genentech, Seattle Genetics.